Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
Julianna Longo

Phone: 206.285.3500

Fax: 206.285.6619

Email: media@path.org

Recent Press Coverage

  1. The Milken Institute School of Public Health at George Washington University announced a partnership with PATH, funded by the Bill & Melinda Gates Foundation, to enhance immunization in countries with conflict
    Published: April 2024
  2. An article announcing the Gates Foundation’s refreshed open access and preprint policy highlights the experience of PATH’s Emmanuel Mugisha, who says researchers in low- and middle-income countries face daily barriers as a result of journal paywalls
    Published: March 2024
  3. The Men5CV (MenFive) pentavalent meningitis vaccine—the result of a 13-year development collaboration between Serum Institute of India and PATH—could help eliminate a leading cause of neurological disease and disability in sub-Saharan Africa.
    Published: March 2024
  4. The New York Times remembers Kent Campbell, the creator and first director of PATH’s Malaria Control and Elimination Partnership in Africa (MACEPA) program. Dr. Campbell is remembered for a legacy of lifesaving work over four decades in public health.
    Published: March 2024

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

957 Item s
957 Item s
    Date
    From
    To
  1. The vaccine's prequalification is a key step in protecting children and reducing the burden of malaria.
    Published: September 2022
    Announcement
  2. The trial aimed to determine how well a new, injectable, non-replicating rotavirus vaccine candidate works compared to a licensed oral rotavirus vaccine in preventing infant diarrhea.
    Published: August 2022
    Announcement
  3. PATH, Vietnam’s Ministry of Health, and The Hepatitis Fund share the results of HepLINK: a novel model of community-based and HIV-integrated viral hepatitis service delivery.
    Published: July 2022
    Press Release
  4. During the 24th International AIDS Conference, PATH will showcase our continued commitment to health equity by supporting communities to lead the delivery of integrated HIV and primary health care (PHC) services and ensuring client needs and preferences shape health care models and technologies.
    Published: July 2022
    Press Release
  5. Published: July 2022
    Announcement